Inhibikase Therapeutics shares owned by Fairmount Funds Management
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Fairmount Funds Management
from 13F filings
Historical chart of Fairmount Funds Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Fairmount Funds Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Fairmount Funds Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.9M | 6.1M | 1.62 |
| 2025-06-30 | $12M | 6.1M | 1.95 |
| 2025-03-31 | $13M | 6.1M | 2.19 |
| 2024-12-31 | $20M | 6.1M | 3.25 |
More positions owned by Fairmount Funds Management
View all positions for Fairmount Funds Management